Clinical Trial

Crownlands Observing Progression With Neurons Study

Study acronym: CROWN-I
Recruiting
View on ClinicalTrials.gov →
Summary
The CROWN-I Study is an observational study to learn about molecular features of Alzheimer's disease (AD) and mild cognitive impairment (MCI). The primary objective is to identify the molecular and genetic modules that differentiate patient subtypes and predict progression of AD. Participants will visit clinical sites to donate samples multiple times and perform virtual and in-person clinical assessments.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-05
Trial Details
NCT Number NCT07611396
Lead Sponsor Crownlands
Conditions Alzheimer s Disease, Mild Cognitive Impairment (MCI)
Enrollment 160 participants
Start Date 2026-05-19
Primary Completion 2028-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-04